psychedelics investing

The Calmer Co. International Limited (ASX: CCO) submits the following Activities Report and Appendix 4C Cash Flow…
Read More...

The Calmer Co. International Limited (ASX: CCO), a leading consumer packaged goods company specialising in kava and…
Read More...

Brisbane, Australia - The Calmer Co. International Limited (ASX: CCO), a leading consumer packaged goods company…
Read More...

The psychedelic medicine market is moving swiftly from speculative research mode toward an institutional,…
Read More...

Pharmaceutical giant Eli Lilly and Company (NYSE:LLY) is pushing further into the psychedelic drug market with a…
Read More...

The landscape for medical cannabis and psychedelic therapies has rapidly shifted in just a few weeks following recent…
Read More...

On April 18, President Trump was joined by top health officials in the Oval Office to sign Accelerating Medical…
Read More...

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”), a leader in innovative mental health treatments, is pleased…
Read More...